-+ 0.00%
-+ 0.00%
-+ 0.00%
Tempus AI to Present Breast Cancer Treatment Prediction Study at 2026 SABCS
Share
Listen to the news
Tempus AI to Present Breast Cancer Treatment Prediction Study at 2026 SABCS
  • Tempus AI will present 16 abstracts at the San Antonio Breast Cancer Symposium, scheduled for Dec. 8-11, 2026.
  • Late-breaking data on Dec. 10 will highlight an AI model's potential to identify outcome differences and treatment benefits in metastatic breast cancer.
  • Another study found HER2 RNA outperformed immunohistochemistry in predicting outcomes with trastuzumab deruxtecan; results will be presented Dec. 9.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611190730BIZWIRE_USPR_____20261119_BW739681) on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending